logo

Stem Cell Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Stem Cell Manufacturing market is segmented by Type (Products such as Culture Media, Consumables, Instruments, Stem Cell Lines and Services), Application, End-User, and Geography.

Home Industry Reports Healthcare Stem Cell Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts ...

Stem Cell Manufacturing Market Snapshot

Stem Cell Manufacturing market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 12.97 %
Stem Cell Manufacturing market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Stem Cell Manufacturing market is projected to grow with a CAGR of nearly 12.9% over the forecast period. The major factors attributing to the growth of the market include the technological advancements in stem cell manufacturing and preservation and growing public awareness about the therapeutic potency of stem cell products.

According to California Institute for Regenerative Medicine, for the millions of people around the world who suffer from incurable diseases and injury, Stem Cell Awareness Day, October 11th is a day to celebrate the scientific advances made to-date. Research and academic institutions and educators are encouraged to participate by hosting public talks and other activities and events in their community. Furthermore, the growing growing public-private investments and funding in stem cell-based research is boosting the market growth. However, the gaining popularity of alternative procedures is the major drawback of market growth.

Scope of the Report

As per the scope of the report stem cell is a cell with the unique ability to develop into particular cell types in the body. In the future, they may be used to replace cells and tissues that have been damaged or lost due to disease.

By Type
Product
Culture Media
Consumables
Instruments
Stem Cell Lines
Services
By Application
Stem Cell Therapy
Drug Discovery and Development
Stem Cell Banking
By End-User
Pharmaceutical and Biotechnology Companies
Cell Banks and Tissue Banks
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Stem Cell Banking Segment is the Fastest Growing Segment in the Stem Cell Manufacturing Market.

Stem cell bank is a provision that stores stem cells developed from amniotic fluid for future use. Stem cell samples in private banks are stored specifically for use by the individual person from whom such cells have been collected and the banking costs are paid the person. The sample can later be recovered only by that individual and for the use by such individual or, in many cases, by her or his first-degree blood relatives.

The major factor driving the growth of the segment is the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation. Furthermore, stem cells have been proven to treat approximately 80 diseases and disorders including hematopoietic disorders, immunodeficiency diseases, metabolic disorders, etc. With the continued increase in per capita disposable revenue across developing countries and an expected decrease in product costs associated with stem cell therapies, increasing public awareness and the adoption of stem cell therapies, are the reasons driving the segment growth.

Stem Cell Manufacturing market Key Trends

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high concentration of stem cell research in the region, mounting public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and raising public awareness on the therapeutic potency of stem cells. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Stem Cell Manufacturing market Growth by Region

Competitive Landscape

The Stem Cell Manufacturing market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Becton, Dickinson and Company, Cellular Dynamics (Fujifilm Holdings Corporation), Lonza Group, Stemcell Technologies, Merck Group, Thermo Fisher Scientific, and Pluristem Therapeutics Inc among others.

Sartorius, Becton, Dickinson and Company, Cellular Dynamics , Lonza Group, Stemcell Technologies, Corning Incorporated, Merck Group, Thermo Fisher Scientific, Pluristem Therapeutics Inc., Miltenyi Biotec

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Stem Cell Manufacturing and Preservation

      2. 4.2.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products

      3. 4.2.3 Growing Public-Private Investments and Funding in Stem Cell-Based Research

    3. 4.3 Market Restraints

      1. 4.3.1 High Operational Costs Associated With Stem Cell Manufacturing and Banking

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Product

        1. 5.1.1.1 Culture Media

        2. 5.1.1.2 Consumables

        3. 5.1.1.3 Instruments

        4. 5.1.1.4 Stem Cell Lines

      2. 5.1.2 Services

    2. 5.2 By Application

      1. 5.2.1 Stem Cell Therapy

      2. 5.2.2 Drug Discovery and Development

      3. 5.2.3 Stem Cell Banking

    3. 5.3 By End-User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Cell Banks and Tissue Banks

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Sartorius

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Cellular Dynamics (Fujifilm Holdings Corporation)

      4. 6.1.4 Lonza Group

      5. 6.1.5 Stemcell Technologies

      6. 6.1.6 Corning Incorporated

      7. 6.1.7 Merck Group

      8. 6.1.8 Thermo Fisher Scientific

      9. 6.1.9 Pluristem Therapeutics Inc.

      10. 6.1.10 Miltenyi Biotec

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Stem Cell Manufacturing Market market is studied from 2018 - 2026.

The Stem Cell Manufacturing Market is growing at a CAGR of 12.97% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Becton, Dickinson and Company, Cellular Dynamics (Fujifilm Holdings Corporation), Lonza Group, Stemcell Technologies, Merck Group are the major companies operating in Stem Cell Manufacturing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!